Salvage Radiation Therapy and Taxotere for PSA Failure After Radical Prostatectomy
Status:
Terminated
Trial end date:
2014-07-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to try to find out whether adding chemotherapy to the
standard treatment for your stage of prostate cancer is more effective than the standard
treatment by itself. The kind of treatment that most physicians would consider standard for
this stage of prostate cancer is radiation therapy alone, possibly in combination with
hormonal therapy. In this study, all patients will receive chemotherapy and radiation
therapy. It is hoped that chemotherapy will be found to provide additional benefit, but
chemotherapy has significant side effects. The use of chemotherapy is experimental in
prostate cancer; it needs to be tested to determine if it is beneficial and to find out more
about the side effects of the two different treatments. This study is to determine the
effects, good and/or bad, of adding chemotherapy to radiation therapy as "salvage" treatment
for recurrent prostate cancer after surgery.
Phase:
Phase 2
Details
Lead Sponsor:
University of Michigan Cancer Center University of Michigan Rogel Cancer Center